4-Hydroxythiobenzamide CAS 25984-63-8 Purity >99.0% (HPLC) Febuxostat Intermediate Factory

Chemical Name: 4-Hydroxythiobenzamide  CAS: 25984-63-8 Purity: >99.0% (HPLC)  Appearance: Pale Yellow Solid Powder Intermediate of Febuxostat (CAS: 144060-53-7) High Quality, Commercial Production E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Febuxostat Related Intermediates: Febuxostat CAS 144060-53-7 Ethyl 2-Chloroacetoacetate CAS 609-15-4 4-Hydroxythiobenzamide CAS 25984-63-8 Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3 Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7 Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4 Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Item Specifications
Appearance Pale Yellow Solid Powder
Purity / Analysis Method >99.0% (HPLC)  
Identification By HPLC; By HNMR
Loss on Drying <0.50%
Residue on Ignition <0.20%
Single Impurity <0.50%
Total Impurities <1.00%
Test Standard Enterprise Standard
Usage Intermediate of Febuxostat (CAS: 144060-53-7)

Description:

Specifications:

Package & Storage:

Chemical Name 4-Hydroxythiobenzamide
Synonyms p-Hydroxythiobenzamide; 4-Hydroxy-thiobenzamide; p-Hydroxythio-benzamide; 4-Hydroxybenzenecarbothioamide; 4-Hydroxybenzothioamide
CAS Number 25984-63-8
CAT Number RF-PI1855
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H7NOS
Molecular Weight 153.20  
Melting Point 181.0~185.0℃
Density 1.338±0.06 g/cm3
Solubility (Soluble in) Soluble in Methanol
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

4-Hydroxythiobenzamide (CAS: 25984-63-8) can be used as an intermediate of Febuxostat (CAS: 144060-53-7). Febuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours